Insufficient scRNA-seq data for expression of SALL2 at single-cell level.
Insufficient scRNA-seq data for expression of SALL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4120.77 | 2641 / 2642 | 100% | 82.39 | 703 / 705 |
thymus | 99% | 1370.67 | 648 / 653 | 92% | 16.07 | 557 / 605 |
ovary | 100% | 1918.15 | 180 / 180 | 89% | 18.27 | 381 / 430 |
prostate | 96% | 860.68 | 236 / 245 | 91% | 11.36 | 457 / 502 |
breast | 77% | 653.74 | 354 / 459 | 83% | 15.37 | 924 / 1118 |
adrenal gland | 86% | 646.91 | 222 / 258 | 68% | 15.58 | 156 / 230 |
uterus | 99% | 1910.11 | 168 / 170 | 45% | 7.02 | 205 / 459 |
lung | 78% | 481.49 | 453 / 578 | 64% | 7.54 | 743 / 1155 |
kidney | 72% | 430.62 | 64 / 89 | 61% | 6.34 | 551 / 901 |
bladder | 95% | 1077.43 | 20 / 21 | 33% | 3.30 | 164 / 504 |
esophagus | 79% | 849.41 | 1140 / 1445 | 28% | 2.66 | 51 / 183 |
skin | 48% | 220.00 | 863 / 1809 | 53% | 6.25 | 250 / 472 |
blood vessel | 97% | 923.86 | 1294 / 1335 | 0% | 0 | 0 / 0 |
intestine | 83% | 1168.00 | 804 / 966 | 8% | 0.67 | 43 / 527 |
pancreas | 36% | 160.73 | 119 / 328 | 54% | 5.05 | 97 / 178 |
stomach | 57% | 603.39 | 205 / 359 | 13% | 1.42 | 37 / 286 |
adipose | 67% | 407.34 | 806 / 1204 | 0% | 0 | 0 / 0 |
spleen | 54% | 231.86 | 131 / 241 | 0% | 0 | 0 / 0 |
heart | 54% | 286.35 | 464 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 40% | 3.18 | 18 / 45 |
eye | 0% | 0 | 0 / 0 | 38% | 3.60 | 30 / 80 |
liver | 0% | 1.39 | 1 / 226 | 23% | 2.02 | 95 / 406 |
peripheral blood | 14% | 97.31 | 130 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.38 | 2 / 29 |
muscle | 2% | 7.30 | 15 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001654 | Biological process | eye development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | SALL2 |
Protein name | Sal-like protein 2 (Zinc finger protein 795) (Zinc finger protein SALL2) (Zinc finger protein Spalt-2) (Sal-2) (hSal2) Spalt like transcription factor 2 |
Synonyms | ZNF795 KIAA0360 SAL2 |
Description | FUNCTION: Probable transcription factor that plays a role in eye development before, during, and after optic fissure closure. . |
Accessions | E7EW59 ENST00000541965.1 ENST00000611430.4 F5H433 ENST00000611430.4 [Q9Y467-3] F5H1G6 ENST00000450879.2 H0YFS7 A0A0B4J2F7 ENST00000614342.1 [Q9Y467-1] ENST00000613414.4 Q9Y467 ENST00000546363.5 A0A087X1T9 ENST00000537235.2 |